Advertisement

Related Videos

Welcome and Introduction to Vi3C

Blase Polite, MD, MPP, FASCO, on Transforming the Drug Cost Curve in the United States: Not How But If

Mark J. Ratain, MD: The Justification for a Randomized Trial of Low-Dose Ibrutinib

CS Pramesh, MS, FRCS, on Opportunities in India: A Perspective From a Low-Middle Income Country

Leonard B. Saltz, MD, on the Future of Interventional Pharmacoeconomics

Advertisement

Advertisement




Oct
13
Today In Oncology
Insurance and Cost Barriers to Oral Therapies for Blood Cancers
Long-Term Disease Control From SBRT Equal to Surgery in Localized Prostate Cancer
Prostate Cancer Higher Saturated Fat Intake May Be Linked to Worse Outcomes
The Wistar Institute Names New President and Chief Executive Officer
Early Research Links Abdominal Obesity to Increased Lung Cancer Risk
View More 
Advertisement
© 2026 HSP News Service, L.L.C.
Conexiant Oncology Logo